HARTFORD — Connecticut is poised to make a new class of costly hepatitis C drugs more accessible to the state's poorest patients.
The state Department of Social Services will classify Sovaldi, Harvoni and Viekira Pak as preferred drugs in its Medicaid program, which means they will be "readily available to our clients,'' said department spokesman David Dearborn.
The department is also simplifying its prior authorization process, which had been criticized by advocates for hepatitis C patients as a tactic designed to limit access to the expensive but highly effective treatments.
Read more...
No comments:
Post a Comment